2019 Novel Coronavirus Disease (COVID-19)
The 2019 novel coronavirus disease (COVID-19) is a virus of global health significance caused by infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is thought to spread from person to person in close contact through respiratory droplets. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic.
Thank you for reading this post, don't forget to subscribe!
At AGPC, our priority remains in the health and safety of our employees, and the healthcare providers, patients and communities we serve, and we are doing our part to deliver answers during these uncertain times.
COVID-19 testing is imperative in helping healthcare providers identify infected and exposed patients more quickly. AGPC has been working expeditiously to develop and offer test services that will yield high quality and accurate results, including a molecular test for helping with COVID-19 diagnosis and a serology test to help indicate possible COVID-19 exposure.
MOLECULAR TEST FOR COVID-19 DIAGNOSIS: AGPC offers a real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) assay, to ensure patients and providers have greater access to testing to promote earlier diagnosis and help limit spread of infection.
SEROLOGY TEST FOR COVID-19 EXPOSURE: AGPC offers a COVID-19 antibody immunoassay which measures SARS-CoV-2 specific antibody levels, correlating with the patient’s immune response after COVID-19 infection.